NPPA fixes retail price of 3 formulations including HIV, Oncology drug Medical Dialogues Team20 Jun 2021 11:30 AM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
NPPA fixes retail price of 12 formulations, Details Medical Dialogues Team6 Jun 2021 11:30 AM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Govt shows green flag to 4 firms under PLI scheme for bulk drugs including Ritonavir, Levofloxacin Ruchika Sharma1 Jun 2021 10:00 AM ISTNew Delhi: Four waitlisted firms have received approval from the Government under the Production Linked Incentive (PLI) scheme for domestic...
ICMR researchers release protocol for administering Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Hina Zahid29 April 2020 2:39 PM ISTNew Delhi: With the Central Drugs Standard Control Organization approving, the restricted public health use of lopinavir/ritonavir combination amongst...
Lopinavir/ritonavir and Arbidol not found effective in COVID-19 Hina Zahid22 April 2020 4:45 PM ISTResearchers have found that lopinavir/ritonavir or Arbidol--antivirals do not benefit patients of mild to moderate Covid 19 v patients.An exploratory...
Kerala Doctors begin using HIV combo drugs on Coronavirus patients Hina Zahid20 March 2020 12:23 PM ISTThe team of doctors here is led by the medical college principal Dr Thomas Mathew. Doctors Fathahuddin, Jacob Jacob, Ganesh Mohan and Geetha Nair are...
No benefit of Lopinavir–Ritonavir combo in severe COVID-19, says NEJM Dr. K B Aarthi19 March 2020 11:45 AM ISTLopinavir acts against the viral 3CL protease have modest antiviral activity and ritonavir increases its plasma half-life through the inhibition of...
HIV drugs in coronavirus patients: ICMR scientists release protocol for restricted public health emergency use Dr. K B Aarthi16 March 2020 12:00 PM ISTLopinavir/ritonavir combination does not remain the mainstay treatment to COVID-19, researchers advise its usage in case of severe cases
